[Acute diarrhea: updates for primary care medicine in 2023].

Rev Med Suisse

Service de médecine de premier recours, Département de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14.

Published: September 2023

AI Article Synopsis

  • *Most patients can recover with just symptomatic treatment, but it's crucial for doctors to identify those needing further tests or antibiotics.
  • *Recent advancements in stool pathogen testing offer pros and cons, and due to resistance issues, azithromycin is now preferred over quinolones for treating infections like Campylobacter and Shigella.

Article Abstract

Acute diarrheal disease is a frequent primary care reason for consultation, leading to direct and indirect health costs in high-income countries. Most patients presenting with acute diarrhea will have a favorable clinical course with just a symptomatic treatment. The challenge for the general practitioner is to identify the patients who need paraclinical exams and/or antibiotics. Molecular identification of pathogens in stool samples has developed over the past years and presents both advantages and limitations. Because of increasing microbial resistance to quinolones in Campylobacter and Shigella strains, azithromycin is now the first choice for an empiric antimicrobial therapy. This article will discuss these latest developments in the management of acute diarrhea in the primary care setting.

Download full-text PDF

Source
http://dx.doi.org/10.53738/REVMED.2023.19.843.1750DOI Listing

Publication Analysis

Top Keywords

primary care
12
acute diarrhea
8
[acute diarrhea
4
diarrhea updates
4
updates primary
4
care medicine
4
medicine 2023]
4
2023] acute
4
acute diarrheal
4
diarrheal disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!